George F. Koob

机构：National Institutes of Health, National Institute on Drug Abuse, American Society of Addiction Medicine, National Drug Addiction Center, National Institute on Alcohol Abuse and Alcoholism · ORCID：0009-0002-9857-4493

发表论文 1013 篇 · 总被引 115063 次 · h-index 170

代表论文

Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake (2025 · Journal of Clinical Investigation · 被引 53)
The HEALthy Brain and Child Development Study (HBCD): NIH collaboration to understand the impacts of prenatal and early life experiences on brain development (2024 · Developmental Cognitive Neuroscience · 被引 48)
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial (2026 · The Lancet · 被引 16)
Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive battery (2024 · Translational Psychiatry · 被引 14)
A conceptual framework for the intersection of hyperalgesia and hyperkatifeia in alcohol addiction (2025 · Alcohol · 被引 13)
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial) (2025 · BMJ Open · 被引 11)